Project Details
Description
A Double-blind, Randomized, Placebo Controlled Intervention Study to Assess the Impact of Sitagliptin 100 mg/day for 1 Year on Insulin Independence following Pancreatecomy and Autoislet Transplantation
Status | Finished |
---|---|
Effective start/end date | 10/6/10 → 7/31/12 |
Funding
- MERCK AND CO INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.